Journal of Turkish Clinical Biochemistry

The official publication of Turkish Society of Clinical Biochemistry

Diamond OA
No APCs
First Decision
30 Days
Indexed In
TR Dizin
Original Research
August 01, 2023
JTCB. 2023 Aug 1; 21 (2) : 110-118
DOI 10.56615/tkbd.2023.14
94 138
PDF

Biochemical Markers in Determining the Risk of Intensive Care Unit Admission in COVID-19

1 Department of Medical Biochemistry, Yerkoy State Hospital, 66900 Yozgat, Turkey
2 Department of Medical Biochemistry, Sorgun State Hospital, 66900 Yozgat, Turkey
3 Department of Medical Biochemistry, Yozgat City Hospital, 66900 Yozgat, Turkey
4 Department of Biochemistry, Dr. Behcet Uz Children’s Hospital, 35210 Izmir, Turkey
5 Department of Medical Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey

Abstract

Aim: It was aimed to determine predictive markers for the need for intensive care unit (ICU) hospitalization in patients with coronavirus infection.

Material and Methods: This study was performed retrospectively from data of patients hospitalized with the diagnosis of Coronavirus 2019 (COVID-19) in Yerkoy State Hospital. A total of 170 patients with a laboratory diagnosis of coronavirus were included. Thorax computed tomography (CT) findings, hematologic data, liver and kidney function tests, lipid profiles, basal hormone data and some vitamin levels were assessed. Gender, age, and length of hospital stay were determined. The existence of an independent relationship between biochemical parameters and the risk of admission to the ICU was investigated by binary logistic regression analysis.

Results: Mean age of participants was 69.12±13.72 years. 145 (85.3%) patients were discharged from the hospital with recovery, and 25 (14.7%) patients were referred to another hospital due to ICU needs. The median length of stay in the hospital was 5 (range 1-64) days. 143 (84.1%) patients had pathology in thorax CT. Length of stay in the hospital was significantly lower in referred patients than in non-ICU patients (p<0.001). Coronary artery disease (CAD) percentage was significantly higher in patients requiring ICU admission (p=0.010). We found no significant differences between non-ICU and ICU patients regarding age, sex, and CT findings. Platelet count (p=0.004) and monocyte percentage (p=0.018) were significantly lower, and Lactate Dehydrogenase (LDH) was significantly higher in patients requiring ICU p=0.007).

Conclusion: The increase in LDH, decrease in platelet and monocyte, and presence of concomitant CAD in patients hospitalized with the diagnosis of COVID-19 may alert physicians regarding the need for ICU.

Citation

Yardim, Meltem, Levent Deniz, Damla Kayalp, Nilüfer Celik, and Burcu Ulas Kahya. 2023. “Biochemical Markers in Determining the Risk of Intensive Care Unit Admission in COVID-19”. Journal of Turkish Clinical Biochemistry 21 (2):110-18. https://doi.org/10.56615/tkbd.2023.14.

Publish with JTCB

Diamond Open Access

Fully Diamond OA with no APCs and no submission fees. Your research is freely available to readers worldwide from the day it publishes.

30-Day First Decision

Double-blind peer review from an active editorial team returns a first decision in about 30 days, keeping your manuscript moving.

Global Platform

Backed by the Turkish Society of Clinical Biochemistry, JTCB welcomes submissions from researchers worldwide and reaches an international laboratory audience.

Focused Laboratory Scope

Method validation, analyzer comparisons, reference intervals, quality indicators, preanalytical studies, and instructive clinical case reports.

Credible and Discoverable

All manuscripts publish in English and follow ICMJE and COPE guidelines, with Crossref DOIs and TR Dizin indexing ensuring global discoverability.